Vaccines
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
News from the FDA/CDC
CDC backs FDA’s call for second COVID booster for those at high risk
The agency is following the recommendations made by its Advisory Committee on Immunization Practices (ACIP).
News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.
Conference Coverage
Parents of patients with rheumatic disease, MIS-C strongly hesitant of COVID vaccination
A single-center study and a survey of rheumatologists revealed similar levels of hesitancy among parents of both these populations.
News from the FDA/CDC
Single bivalent COVID booster is enough for now: CDC
Booster strength wanes after a few months, spurring discussions of whether people at high risk of getting a severe case of COVID may need more...
News
Negative expectations of COVID shots may amplify side effects
It fits the psychosomatic role of “nocebo effects.”
News
Nasal COVID treatment shows early promise against multiple variants
Unlike a COVID vaccine that boosts a person’s immune system as protection, the antiviral nasal spray works more directly by blocking the virus,...
Opinion
COVID-19 vaccinations lag in youngest children
As of March 1, 2023, only 8% of children under 2 years and 10.5% of children ages 2-4 years have initiated a COVID vaccine series.
News
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.